Press releases

Article reported on a study that found about 20 percent of patients who received an implantable cardioverter defibrillator (ICD) did not meet evidence-based guidelines

Acquisition brings Boston Scientific the first fully repositionable device for percutaneous aortic valve replacement to treat severe aortic stenosis

Company prepays $600 million of debt

Company will participate in the conference on January 11, 2011. A live webcast and replay will be available.

Distinguished leader brings broad range of expertise in science, technology, business, education and government